Company Monitoring Page for MannKind

latest headlines for company on cafepharma

MannKind, Vical, GTx: Investors Predict Pivotal Clinical Trial Results
TheStreet.com
Mon, 08/5/13 - 07:23 am
Tags:
MannKind, Vical, clinical trials, GTx, diabetes, Afrezza, melanoma, Allovectin-7, enobosarm, lung cancer-related muscle wasting
BioPharma Catalyst Trade Pick Of The Week: Biodel
Seeking Alpha
Tue, 07/30/13 - 11:43 am
Tags:
MannKind, Eli Lilly, Biodel, Astex
3 Biotech Catalysts Primed To Be Successful In Q3
Seeking Alpha
Wed, 07/24/13 - 09:48 am
Tags:
BIOD-123, Biodel, MannKind, Afrezza, GTx
Novo Nordisk: A Pure Play In The Large And Lucrative Diabetes Care Sector
Seeking Alpha
Tue, 07/23/13 - 11:14 am
Tags:
Novo Nordisk, diabetes, MannKind, Merck
[video]Inhaled Insulin: Biotech Triumph or Future Flop?
Motley Fool
Mon, 07/8/13 - 10:37 am
Tags:
inhaled insulin, Afrezza, MannKind, diabetes
MannKind announces $160M debt financing
Yahoo/Fly on the Wall
Mon, 07/1/13 - 11:52 am
Tags:
MannKind
New AMA Obesity Ruling Should Push Big Pharma To Find Acquisitions
Seeking Alpha
Thu, 06/27/13 - 09:59 am
Tags:
obesity, M&A, Oramed, AstraZeneca, MannKind, Merck, Sanofi, Novo Nordisk
Summer Street 'much more optimistic' about MannKind approval
The Fly on the Wall
Fri, 06/21/13 - 09:15 am
Tags:
MannKind, drug approvals, Afrezza, diabetes
10 Most-Shorted Biotech Stocks of 2013
TheStreet.com
Thu, 06/20/13 - 12:24 pm
Tags:
InterMune, Hyperion, Arena Pharmaceuticals, Sunesis, Synta Pharmaceuticals, Ziopharm, MannKind, Dendreon, Spectrum Pharmaceuticals, Sarepta Therapeutics
2 Biotech Approval Outcomes That Might Affect You
Motley Fool
Wed, 06/19/13 - 11:08 am
Tags:
drug approvals, Afrezza, MannKind, Contrave, Orexigen
Five Best-Performing Biotech Stocks of 2013 (Some May Surprise You)
TheStreet.com
Tue, 06/11/13 - 10:14 am
Tags:
Acadia, Clovis Oncology, MannKind, Chelsea Therapeutics, Keryx
Can Mannkind Deliver A Summer Blockbuster?
Seeking Alpha
Tue, 06/11/13 - 09:16 am
Tags:
MannKind, diabetes, Afrezza
MannKind Corporation (MNKD): Today's Featured Drugs Laggard
The Street
Sat, 06/8/13 - 10:09 am
Tags:
MannKind
Biotech Stock Mailbag: 2013 Clinical Trials Calendar
TheStreet.com
Fri, 06/7/13 - 08:07 am
Tags:
Zerenex, Xoma, Vical, Takeda, sovaprevir, Soluble Ferric Pyrophosphate, Rockwell Medical, Orexigen, MM-398, Merrimack Pharmaceuticals, MannKind, Keryx, GTx, GSK, gevokizumab, enobosarm, Coronado Biosciences, Contrave, CNDO-201, clinical trials, ChemoCentryx, CCX140, Biodel, BIOD-123, Amigal, Amicus Therapeutics, Alnylam, ALN-TTR02, Allovectin, Afrezza, Achillion, ACH-3102
MannKind: It All Comes Down To This
Seeking Alpha
Wed, 06/5/13 - 12:17 pm
Tags:
MannKind, Afrezza
MannKind Completes Phase 3 Clinical Study of AFREZZA in Patients with Type 1 Diabetes
Yahoo
Fri, 05/31/13 - 04:37 pm
Tags:
type 1 diabetes, MannKind, Afrezza, inhaled insulin
The Run-Up Trade: Biodel's Insulin Trial Results
TheStreet.com
Thu, 05/30/13 - 09:01 am
Tags:
insulin, diabetes, Biodel, BIOD-123, MannKind, Afrezza
3 Humongous Health Care Stocks This Week
Motley Fool
Sat, 05/25/13 - 11:54 am
Tags:
MannKind, Vivus, Ariad Pharmaceuticals
MannKind shares leap as web site says firm is a ripe takeover target
MarketWatch
Sat, 05/25/13 - 11:46 am
Tags:
MannKind
Biotech Stock Mailbag: Amarin, MannKind, Palatin
The Street
Fri, 05/24/13 - 10:45 am
Tags:
Amarin, MannKind, Palatin

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.